Florencia Merino was sifting through the nucleus of a neural stem cell in a Munich lab when she stumbled upon something no one expected—dozens of cytoskeletal proteins, including MAP1B, quietly at work inside the command center of the cell. At Helmholtz Munich and Ludwig Maximilian University, Merino and her mentor, Prof. Magdalena Götz, have rewritten a fundamental assumption in developmental biology: the cytoskeleton, long seen as the cell’s structural scaffold, also operates deep within the nucleus to shape how the brain forms.
For decades, scientists studied brain development by separating two cellular worlds—the cytoplasm, where the cytoskeleton governs shape and movement, and the nucleus, where DNA programs unfold. But Götz’s team found this division too neat. By isolating nuclei from both embryonic mouse brain cells and human stem cell–derived neural precursors, they discovered that cytoskeletal proteins are not just visitors in the nucleus—they’re key players. Among them, MAP1B stood out. Known for its role in cell differentiation, MAP1B was already linked to periventricular heterotopia, a rare brain disorder where neurons fail to migrate to their proper layers. But the team’s breakthrough revealed a deeper origin.
When MAP1B functions in the cytoplasm, it helps neural stem cells turn into neurons. But inside the nucleus, it does the opposite—binding to different protein complexes to keep stem cells in their undifferentiated state longer. This dual role means that mutations in MAP1B don’t just disrupt cell movement; they alter cell identity from the very start. In experiments with human brain organoids carrying MAP1B mutations, the team observed delayed differentiation and mispositioned neurons—mimicking the hallmark traits of periventricular heterotopia. The disorder, it turns out, isn’t just about faulty migration. It begins earlier, in the stem cell’s developmental programming.
This shift in understanding could reshape how scientists approach neurodevelopmental conditions. By tracing disorders back to nuclear roles of structural proteins, new diagnostic and therapeutic avenues may emerge. The team’s work, published in Cell, underscores a profound truth: even the most established cellular boundaries can hide surprises.
As brain organoid models grow more sophisticated, researchers like Merino and Götz are peering deeper into the earliest moments of human development—where a single protein, in the wrong compartment, can alter the course of a life.